查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| HLIT Harmonic Inc. Common Stock | 0.38 2026-12-31 | 0.34 – 0.42 | 3 | +13.86% | +13.86% | -25.32% | 2 / 1 | $486.88M |
| REGN Regeneron Pharmaceuticals Inc. Common Stock | 50.38 2026-12-31 | 45.77 – 58.33 | 20 | +9.87% | +9.01% | +8.63% | 0 / 1 | $16.66B |
| GRMN Garmin Ltd. Common Stock (Switzerland) | 10.06 2026-12-31 | 10 – 10.25 | 5 | +5.02% | +5.02% | +6.13% | 3 / 2 | $8.1B |
| WST West Pharmaceutical Services Inc. Common Stock | 8.94 2026-12-31 | 8.58 – 9.05 | 16 | +2.73% | +3.78% | +3.66% | 1 / 1 | $3.37B |
| FMNB Farmers National Banc Corp. Common Stock | 1.68 2026-12-31 | 1.66 – 1.7 | 3 | +3.50% | +3.50% | +3.50% | 1 / 2 | $269.75M |
| HRMY Harmony Biosciences Holdings Inc. Common Stock | 4.52 2026-12-31 | 3.38 – 5.35 | 4 | +0.59% | +2.99% | +1.07% | 0 / 2 | $1.02B |
| ARM Arm Holdings plc American Depositary Shares | 2.23 2027-03-31 | 2.06 – 2.42 | 33 | +2.36% | +2.24% | +3.74% | 5 / 3 | $6.05B |
| RPRX Royalty Pharma plc Class A Ordinary Shares | 5.23 2026-12-31 | 5.05 – 5.33 | 6 | +2.07% | +2.15% | +2.60% | 4 / 1 | $3.47B |
| AWI Armstrong World Industries Inc Common Stock | 8.44 2026-12-31 | 8.35 – 8.5 | 10 | +1.56% | +1.48% | +1.47% | 5 / 4 | $1.79B |
| KMX CarMax Inc | 2.73 2027-02-28 | 2.46 – 3.16 | 14 | +0.92% | +0.98% | +16.23% | 8 / 1 | $27.09B |
| KRMN Karman Holdings Inc. Common Stock | 0.58 2026-12-31 | 0.46 – 0.64 | 10 | 0.00% | +0.94% | -12.27% | 1 / 0 | $731.64M |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | 9.18 2026-12-31 | 8.79 – 9.68 | 8 | +0.30% | +0.91% | +6.33% | 2 / 2 | $289.77M |
| INDV Indivior Pharmaceuticals Inc. Common Stock | 3.85 2026-12-31 | 3.63 – 4.05 | 5 | +0.78% | +0.78% | +23.49% | 4 / 0 | $1.26B |
| AMRX Amneal Pharmaceuticals Inc. Class A Common Stock | 0.99 2026-12-31 | 0.94 – 1.03 | 5 | +1.43% | +0.64% | -0.35% | 2 / 1 | $3.14B |
| COLL Collegium Pharmaceutical Inc. Common Stock | 7.76 2026-12-31 | 7.29 – 8.18 | 4 | +0.58% | +0.58% | +5.19% | 4 / 1 | $869.86M |
| ANIP ANI Pharmaceuticals Inc. | 9.42 2026-12-31 | 9.19 – 9.68 | 8 | +0.11% | +0.58% | +3.83% | 7 / 0 | $1.12B |
| ARMK Aramark Common Stock | 2.25 2026-09-30 | 2.19 – 2.34 | 15 | +0.21% | +0.20% | +1.26% | 0 / 3 | $19.97B |
| ALRM Alarm.com Holdings Inc. Common Stock | 2.78 2026-12-31 | 2.67 – 2.82 | 6 | +0.13% | +0.13% | -0.48% | 1 / 0 | $1.07B |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | 1.26 2026-12-31 | 1.2 – 1.34 | 6 | 0.00% | 0.00% | +2.94% | 3 / 0 | $1.41B |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | 2.49 2026-12-31 | 2.11 – 2.95 | 3 | 0.00% | 0.00% | +6.27% | 0 / 0 | $867.18M |
| SFM Sprouts Farmers Market Inc. Common Stock | 5.56 2026-12-31 | 5.36 – 5.62 | 9 | +0.22% | -0.03% | +0.10% | 8 / 3 | $9.49B |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | 4.93 2026-12-31 | 4.86 – 5.03 | 17 | -0.10% | -0.05% | -7.84% | 1 / 0 | $3.87B |
| JAZZ Jazz Pharmaceuticals plc Common Stock (Ireland) | 25.31 2026-12-31 | 24.38 – 26.99 | 17 | -0.30% | -0.32% | +4.79% | 0 / 1 | $4.51B |
| ARR ARMOUR Residential REIT Inc. | 2.91 2026-12-31 | 2.89 – 2.94 | 6 | -0.73% | -0.48% | -0.59% | 0 / 1 | $315M |
| RIGL Rigel Pharmaceuticals Inc. Common Stock | 2.89 2026-12-31 | 0.64 – 4.01 | 4 | -0.77% | -0.77% | -39.72% | 0 / 1 | $278.89M |
| VRTX Vertex Pharmaceuticals Incorporated Common Stock | 18.98 2026-12-31 | 17.61 – 19.85 | 20 | +0.07% | -0.88% | -0.61% | 14 / 10 | $13.05B |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | 0.95 2026-12-31 | 0.85 – 1.04 | 5 | -1.04% | -1.04% | +21.28% | 1 / 0 | $325.82M |
| ASND Ascendis Pharma A/S Ordinary Share | 11.73 2026-12-31 | 4.11 – 16.83 | 4 | -0.72% | -2.43% | +316.13% | 0 / 0 | $1.34B |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | 2.6 2026-12-31 | 2.26 – 2.94 | 7 | -0.87% | -2.88% | -20.36% | 0 / 1 | $746.37M |
| ALNY Alnylam Pharmaceuticals Inc. Common Stock | 9.09 2026-12-31 | 8.22 – 9.92 | 12 | -3.58% | -3.55% | -1.98% | 0 / 1 | $5.58B |
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | 2.14 2026-12-31 | 1.91 – 2.94 | 12 | -0.78% | -3.63% | -10.64% | 0 / 4 | $16.58B |
| ACAD ACADIA Pharmaceuticals Inc. Common Stock | 0.37 2026-12-31 | 0.27 – 0.51 | 13 | 0.00% | -4.07% | -24.73% | 0 / 1 | $1.24B |
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | 1.13 2026-12-31 | 1.07 – 1.18 | 3 | -2.30% | -5.56% | -3.96% | 0 / 0 | $993.71M |
| AAPG Ascentage Pharma Group International American Depository Shares | -1.52 2026-12-31 | -2.5 – -0.43 | 5 | — | — | — | 0 / 5 | $861.06M |
| ABOS Acumen Pharmaceuticals Inc. Common Stock | -1.58 2026-12-31 | -1.76 – -1.32 | 3 | — | — | — | 2 / 0 | $0 |
| AGIO Agios Pharmaceuticals Inc. Common Stock | -6.14 2026-12-31 | -7.21 – -5.5 | 7 | — | — | — | 0 / 1 | $130.56M |
| AMLX Amylyx Pharmaceuticals Inc. Common Stock | -1.43 2026-12-31 | -1.59 – -1.27 | 7 | — | — | — | 3 / 4 | $0 |
| ARWR Arrowhead Pharmaceuticals Inc. Common Stock | -3.08 2026-09-30 | -3.82 – -1.85 | 11 | — | — | — | 2 / 0 | $442.33M |
| ATYR aTyr Pharma Inc. Common Stock | -0.56 2026-12-31 | -0.76 – -0.43 | 8 | — | — | — | 4 / 0 | $0 |
| AVBP ArriVent BioPharma Inc. Common Stock | -4.09 2026-12-31 | -4.62 – -3.62 | 11 | — | — | — | 0 / 2 | $0 |
| BBIO BridgeBio Pharma Inc. Common Stock | -2.14 2026-12-31 | -2.58 – -1.5 | 8 | — | — | — | 3 / 1 | $961.16M |
| BNTC Benitec Biopharma Inc. Common Stock | -1 2026-06-30 | -1.07 – -0.96 | 6 | — | — | — | 4 / 0 | $0 |
| CBIO Crescent Biopharma Inc. Common Stock | -2.49 2026-12-31 | -2.73 – -2.22 | 3 | — | — | — | 0 / 1 | $2.08M |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | -1.05 2026-12-31 | -1.14 – -0.8 | 5 | — | — | — | 4 / 0 | $41.83M |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | -4.57 2026-12-31 | -5.7 – -3.31 | 10 | — | — | — | 4 / 4 | $1.11M |
| CRNX Crinetics Pharmaceuticals Inc. Common Stock | -4.62 2026-12-31 | -5.28 – -3.48 | 13 | — | — | — | 0 / 1 | $68.49M |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | -0.71 2026-12-31 | -0.8 – -0.65 | 4 | — | — | — | 0 / 3 | $0 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | -0.87 2026-12-31 | -0.92 – -0.77 | 4 | — | — | — | 2 / 0 | $0 |
| ENTA Enanta Pharmaceuticals Inc. Common Stock | -1.88 2026-09-30 | -2.27 – -1.39 | 4 | — | — | — | 2 / 1 | $66.34M |
| EPRX Eupraxia Pharmaceuticals Inc. Common Stock | -0.98 2026-12-31 | -1.17 – -0.78 | 8 | — | — | — | 0 / 5 | $0 |
| FENC Fennec Pharmaceuticals Inc. Common Stock | 0.3 2026-12-31 | 0.18 – 0.47 | 5 | -2.95% | — | -52.87% | 4 / 2 | $69.83M |
| FPI Farmland Partners Inc. Common Stock | 0.18 2026-12-31 | 0.16 – 0.21 | 3 | — | — | — | 2 / 0 | $44.95M |
| IMMX Immix Biopharma Inc. Common Stock | -0.71 2026-12-31 | -0.87 – -0.57 | 8 | — | — | — | 3 / 1 | $0 |
| IONS Ionis Pharmaceuticals Inc. Common Stock | -2.65 2026-12-31 | -2.69 – -2.62 | 4 | — | — | — | 1 / 0 | $926.6M |
| IPHA Innate Pharma S.A. ADS | -0.55 2026-12-31 | -0.65 – -0.46 | 3 | — | — | — | 0 / 1 | $31.21M |
| KPTI Karyopharm Therapeutics Inc. Common Stock | -4.95 2026-12-31 | -6.03 – -3.58 | 3 | — | — | — | 1 / 0 | $138.21M |
| LBRX LB Pharmaceuticals Inc Common Stock | -3.35 2026-12-31 | -3.72 – -2.75 | 7 | — | — | — | 4 / 0 | $0 |
| LXRX Lexicon Pharmaceuticals Inc. Common Stock | -0.16 2026-12-31 | -0.18 – -0.14 | 5 | — | — | — | 2 / 0 | $38.17M |
| LYEL Lyell Immunopharma Inc. Common Stock | -7.64 2026-12-31 | -8.62 – -6.87 | 8 | — | — | — | 1 / 0 | $11.71K |
| MIST Milestone Pharmaceuticals Inc. Common Shares | -0.83 2026-12-31 | -0.99 – -0.74 | 4 | — | — | — | 0 / 2 | $5.39M |
| MREO Mereo BioPharma Group plc American Depositary Shares | -0.03 2026-12-31 | -0.04 – -0.02 | 5 | — | — | — | 1 / 1 | $7.09M |
| NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares | -1.6 2026-12-31 | -1.84 – -1.36 | 13 | — | — | — | 0 / 1 | $22.88M |
| NGEN NervGen Pharma Corp. Common stock | -0.27 2026-12-31 | -0.29 – -0.23 | 4 | — | — | — | 2 / 0 | $0 |
| NSRX Nasus Pharma Ltd. Ordinary Shares | -1.39 2026-12-31 | -2.22 – -0.93 | 3 | — | — | — | 0 / 0 | $0 |
| NVCT Nuvectis Pharma Inc. Common Stock | -1.01 2026-12-31 | -1.16 – -0.88 | 5 | — | — | — | 1 / 0 | $0 |
| OFRM Once Upon a Farm PBC Common Stock | -0.33 2026-12-31 | -0.47 – -0.25 | 5 | — | — | — | 0 / 5 | $319.76M |
| OLMA Olema Pharmaceuticals Inc. Common Stock | -2.27 2026-12-31 | -2.62 – -1.95 | 9 | — | — | — | 4 / 5 | $0 |
| ORIC Oric Pharmaceuticals Inc. Common Stock | -1.47 2026-12-31 | -1.66 – -1.3 | 13 | — | — | — | 2 / 8 | $0 |
| PHAR Pharming Group N.V. ADS each representing 10 ordinary shares | 0.23 2026-12-31 | 0.05 – 0.57 | 3 | — | — | — | 0 / 0 | $398.09M |
| PHAT Phathom Pharmaceuticals Inc. Common Stock | -0.08 2026-12-31 | -0.13 – -0.01 | 3 | — | — | — | 1 / 1 | $326.35M |
| RARE Ultragenyx Pharmaceutical Inc. Common Stock | -4.19 2026-12-31 | -4.27 – -4.12 | 3 | — | — | — | 0 / 2 | $748.3M |
| RCKT Rocket Pharmaceuticals Inc. Common Stock | -0.75 2026-12-31 | -1.98 – -0.12 | 6 | — | — | — | 2 / 1 | $17.17M |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | -0.92 2026-12-31 | -1 – -0.84 | 6 | — | — | — | 6 / 0 | $64.74M |
| RYTM Rhythm Pharmaceuticals Inc. Common Stock | -3.26 2026-12-31 | -3.87 – -2.82 | 11 | — | — | — | 1 / 0 | $299.04M |
| SGP SpyGlass Pharma Inc. Common Stock | -2.31 2026-12-31 | -2.9 – -1.92 | 3 | — | — | — | 1 / 1 | $0 |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | -1.6 2026-12-31 | -2.2 – -1.16 | 11 | — | — | — | 1 / 1 | $344.78M |
| SPRY ARS Pharmaceuticals Inc. Common Stock | -1.72 2026-12-31 | -2.05 – -1.27 | 3 | — | — | — | 2 / 0 | $139.84M |
| TLX Telix Pharmaceuticals Limited American Depositary Shares | 0.07 2026-12-31 | -0.04 – 0.24 | 5 | — | — | — | 1 / 0 | $1.4B |
| UAA Under Armour Inc. Class A Common Stock | 0.11 2027-03-31 | 0.08 – 0.14 | 23 | — | — | — | 0 / 0 | $4.93B |
| URGN UroGen Pharma Ltd. Ordinary Shares | -0.71 2026-12-31 | -1.7 – -0.15 | 8 | — | — | — | 1 / 0 | $276.49M |
| VITL Vital Farms Inc. Common Stock | -0.42 2026-12-31 | -0.52 – -0.3 | 7 | — | — | — | 0 / 0 | $775.31M |
| VNDA Vanda Pharmaceuticals Inc. Common Stock | -2.27 2026-12-31 | -2.68 – -1.98 | 4 | — | — | — | 3 / 2 | $262.1M |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | -1.73 2026-12-31 | -1.83 – -1.57 | 3 | — | — | — | 2 / 0 | $25.53M |
| XENE Xenon Pharmaceuticals Inc. Common Shares | -4.81 2026-12-31 | -5.94 – -3.88 | 16 | — | — | — | 6 / 7 | $2.07M |
| XERS Xeris Biopharma Holdings Inc. Common Stock | 0.14 2026-12-31 | 0.11 – 0.19 | 4 | — | — | — | 2 / 1 | $385.94M |
| XFOR X4 Pharmaceuticals Inc. Common Stock | -0.73 2026-12-31 | -0.96 – -0.63 | 5 | — | — | — | 2 / 0 | $9.6M |
| ZNTL Zentalis Pharmaceuticals Inc. Common Stock | -1.67 2026-12-31 | -2.19 – -1.33 | 6 | — | — | — | 0 / 1 | $0 |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。